n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, February 22nd, 2018

The QualityStocks
Daily Stock List

graphic
graphic

Provectus Biopharmaceuticals, Inc. (PVCT)

The Street, TopStockAnalysts, plrinvest, Investors Underground, Real Pennies, PennyStocks24, Club Penny Stocks Network, StreetAuthorityDaily, TheMicrocapNews, Streetwise Reports, AllPennyStocks, Stock News Now, Seeking Alpha, TopPennyStockMovers, StreetInsider, and Wise Alerts reported earlier on Provectus Biopharmaceuticals, Inc. (PVCT), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Provectus Biopharmaceuticals, Inc. is a clinical-stage oncology and dermatology Biopharmaceutical Company. It is developing new therapies for the treatment of solid tumor cancers and dermatologic diseases. The Company’s investigational oncology drug is PV-10. PV-10 is an oncolytic immunotherapy enrolling patients in Phase 3 clinical trials for metastatic melanoma. Provectus Biopharmaceuticals is headquartered in Knoxville, Tennessee.

PV-10 is an ablative immunotherapy under investigation in solid tumor cancers. PH-10 is a topical investigational drug for dermatology. It is undergoing clinical testing for psoriasis and atopic dermatitis.

The Company completed Phase 2 trials of PV-10 as a therapy for metastatic melanoma, and of PH-10 as a topical treatment for atopic dermatitis and psoriasis. The intention of PV-10 is to kill only diseased cells upon injection into tumors. Provectus Biopharmaceuticals has received orphan drug designations from the Food and Drug Administration (FDA) for its melanoma and hepatocellular carcinoma indications.

PV-10 is a 10 percent solution of small molecule and halogenated xanthene Rose Bengal. It undergoes administration via direct injection into solid tumor cancers, such as melanoma, liver, and breast. It is not designed to rely on a single pathway, receptor or antigen to work; and there is no known resistance. PH-10 is a topical hydrogel formulation. It yields selective delivery of rose bengal disodium to epithelial tissues.

Regarding PH-10 for psoriasis and atopic dermatitis, a mechanism of action study is underway to measure the clinical and cellular response to PH-10's active investigational agent. A total of 226 subjects have been treated with PH-10 in Phase 1 or Phase 2 Clinical Trials.

Provectus Biopharmaceuticals earlier announced that results from its mechanism of action (MOA) study of PH-10 were presented at the 8th International Congress of Psoriasis: from gene to clinic (Psoriasis G2C), held in London, England from November 30 to December 2, 2017. The MOA work was undertaken by James Krueger, MD, PhD and other members of the Laboratory for Investigative Dermatology at The Rockefeller University.

Mr. Dominic Rodrigues, Chairman of Provectus Pharmaceuticals’ Board of Directors, said, “This study has elucidated PH-10’s novel mechanism of action for psoriasis and, combined with Provectus’ prior clinical work in inflammatory dermatoses, reaffirmed our belief that the Company’s therapeutic platform may now encompass psoriasis and also extend to other skin disorders. The immunologic response outcome that four weeks of topical PH-10 achieved in this study occurs with other topical or systemic drugs approved for psoriasis.”

Today, Provectus Biopharmaceuticals provided an update on its gastrointestinal (GI) cancer clinical development program for its lead investigational drug PV-10, which is administered percutaneously when targeting GI cancer tumors.

The Company’s Phase 1 study of patients with hepatic lesions has treated 18 patients at four U.S. sites to date: six patients with hepatocellular carcinoma (HCC), six patients with metastatic colorectal cancer (mCRC) metastatic to the liver, and six patients with breast cancer, lung cancer, melanoma, ovarian cancer or pancreatic cancer liver metastases.

Results included two of six patients with HCC who remained alive for 58 and 75 months after treatment, the latter with no evidence of disease. Results also included four of five patients with mCRC liver metastases who remained alive 9 to 73 months after treatment. This includes one patient with no evidence of disease at 73 months. Furthermore, results included one patient with pancreatic cancer liver metastases who remained alive 12 months after treatment.

Provectus Biopharmaceuticals, Inc. (PVCT), closed Thursday's trading session at $0.0805, up 1.90%, on 531,339 volume with 56 trades. The average volume for the last 60 days is 1,013,591 and the stock's 52-week low/high is $0.0183/$0.092.

Barfresh Food Group, Inc. (BRFH)

The Wall Street Transcript, SmallCap Network, Wall Street Resources, Greenbackers, OTCJournal, RedChip, Lions of Wall Street, Barchart, Marketbeat, and SmallCapVoice reported earlier on Barfresh Food Group, Inc. (BRFH), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Barfresh Food Group, Inc. is a manufacturer and distributor of innovative, frozen, ready-to-blend beverages. These include smoothies, shakes, and frappes. These products are chiefly for restaurant chains and the foodservice industry. Barfresh Food Group and Barfresh Food Group Pty Ltd. in Australia (Barfresh Australia) are under common control. OTCQB-listed, Barfresh Food Group is headquartered Beverly Hills, California.

The Company acquired the exclusive worldwide patent rights to its ready-to-blend beverage packs. This is on top of its currently held patent rights in the U.S. and Canada.

With this acquisition, Barfresh Food Group gains exclusive rights to service important global markets. These include, but are not limited to China, Europe, Japan, Brazil, and Australia and New Zealand. The rights acquired by Barfresh include all international patents and trademarks covered under the international Patent Cooperation Treaty.

The Company has acquired the intellectual property (IP) for its creative “ready to blend” ingredient packs for North America. Its proprietary, patented system uses portion-controlled pre-packaged beverage ingredients. These deliver freshly made smoothies that are fast, cost efficient, and without waste.

This unique system combines all the ingredients of a quality smoothie into an individually pre-portioned pack. The pack contains real fruit pieces, low fat frozen yogurt or sorbet, fruit juice, and the ice. This is then blended with water to produce a smoothie.

Pertaining to Barfresh Food Group’s Education Channel expansion, the Company previously announced the introduction of a new range of smoothies in response to customer demand, which fulfills the requirements set forth by the USDA (United States Department of Agriculture) within its national school meal programs that provide the mechanism via which schools can be reimbursed for daily meals.

Barfresh Food Group is addressing this market with a product that contains a minimum of a half cup of real fruit and four ounces of yogurt for every eight ounce serving. This product has no added sugar and no artificial ingredients or preservatives. In addition, it meets all the restricted calorie requirements among other criteria.

This month, Barfresh Food Group announced that it expanded its education program to 77 schools with the recent addition of 37 new schools throughout four States. The expansion builds upon Barfresh’s initial soft launch with Pasco County School District in Florida to supply Barfresh frozen beverages at 30 of their middle and high school cafeterias, and also its Canadian placement in 10 schools.

Barfresh Food Group is offering four all-natural, “no sugar added” products specifically formulated for the education channel to meet USDA guidelines under its Child Nutrition Program that permits schools to seek reimbursement for meals served.

Barfresh Food Group, Inc. (BRFH), closed Thursday's trading session at $0.46, up 2.22%, on 602,159 volume with 22 trades. The average volume for the last 60 days is 80,814 and the stock's 52-week low/high is $0.351/$0.82.

Innovative Food Holdings, Inc. (IVFH)

The Bowser Report, Marketbeat, Stock Guru, and FeedBlitz reported earlier on Innovative Food Holdings, Inc. (IVFH), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Innovative Food Holdings, Inc. is an industry leading specialty food platform. The Company, through its subsidiaries, is a foremost nationwide provider of direct from source specialty foods, healthcare foods, gluten free foods, and artisanal foods, to the professional foodservice market. Perishable product is delivered direct to the Company’s kitchen the next day via overnight delivery. Non-perishable product is delivered direct to customers. Innovative Food Holdings is headquartered in Bonita Springs, Florida.

For Chefs (Chef Direct), the Company’s vertically-integrated platform enables it to source 7,000-plus specialty foods from around the world and deliver within 24-72 hours. Innovative Food Holdings’ subsidiaries include Artisan Specialty Foods and Innovative Gourmet.

Artisan Specialty Foods is a nationwide specialty food distributer, re-packer, and importer. Artisan serves hundreds of customers in the Chicago area. Additionally, it serves as a nationwide fulfillment center for other Innovative Food Holdings subsidiaries operating in the foodservice and direct-to-consumer markets.

In the direct-to-chef foodservice market, available products include origin specific seafood, exotic meats and game, dry-aged meats, exotic fruits and vegetables, specialty chocolates, artisanal cheeses, and imported specialties. In addition, available products include caviar, wild and cultivated mushrooms, micro-greens, heirloom and baby produce, organic farmed and manufactured food products, estate-bottled olive oils, aged vinegars, and healthcare food products.

Innovative Food Holdings supplies chefs with unique, organic, sustainable, and artisanal products sourced from all areas internationally. The Company markets its products directly to the consumer, by way of its website at www.forthegourmet.com/.

The Company serves restaurants, hotels, country clubs, national chain accounts, casinos, and catering houses. Many of its products are used each day by a host of some of the top professional chefs throughout the United States.

At the end of January 2018, Innovative Food Holdings announced that its subsidiary, Innovative Gourmet, acquired substantially all the assets of one of North America’s top online gourmet food and gift retailers. The business will operate under igourmet’s valued and trusted trade name.

Mr. Sam Klepfish, Innovative Food Holdings’ Chief Executive Officer, said, “The acquisition of igourmet’s business is synergistic to our current mission of providing small specialty food companies direct access to the kitchens of end users nationwide. Our professional management systems will benefit igourmet and they will serve as an additional distribution center for us.”

igourmet offers a broad variety of high quality gourmet and specialty food products by way of www.igourmet.com, and via a full line of omnichannel partners. Furthermore, igourmet offers an extensive array of specialty food products to restaurants, specialty retailers and other business establishments through its specialty foodservice division.

Innovative Food Holdings, Inc. (IVFH), closed Thursday's trading session at $1.12, even for the day, on 137,812 volume with 95 trades. The average volume for the last 60 days is 141,468 and the stock's 52-week low/high is $0.455/$1.38.

Kraken Robotics, Inc. (KRKNF)

4-Traders, Barchart, Stockhouse, OTC Markets, Morningstar, InvestorsHangout, and TradingView reported on Kraken Robotics, Inc. (KRKNF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Kraken Robotics, Inc.’s devotion is to the production and sale of software, sensors, and robotic systems for the global Unmanned Maritime Vehicles market. The Company’s wholly-owned subsidiary is Kraken Robotic Systems, Inc. On September 20, 2017, Kraken Sonar, Inc. announced that it changed its name from Kraken Sonar, Inc. to Kraken Robotics, Inc. Effective Friday, September 22, 2017; it began trading under its new name.

A marine technology company, Kraken Robotics is based in St. John’s, NL (Newfoundland and Labrador). The Company also has offices in Dartmouth, Nova Scotia; Bremen, Germany; and Fairfax, Virginia.

Kraken Robotics’ series of SAS (Synthetic Aperture Sonar) products called AquaPix® leverages close to 20 years of research and development (R&D) conducted by NATO’s Undersea Research Centre and millions of dollars in funding support from NATO government sponsors. AquaPix® provides comparable performance to existing high end military systems at a lesser cost.

AquaPix® can provide detailed seabed images with a constant resolution better than 3cm x 3cm out to a range of 300m from each side of an underwater vehicle (600m swath). In addition, it can produce 3D bathymetric data with a resolution better than 25cm x 25cm out to full range. This is while delivering very high depth accuracy, in compliance with IHO S44 special order requirements.

Kraken Robotics has expanded from sensors to complete systems. The Company has introduced its KATFISH™ tethered underwater vehicle. Moreover, it has introduced the THUNDERFISH® autonomous underwater vehicle (AUV).

In addition, the Company has its AQUATRAK® CVL product. This speed sensor is a derivative of its SAS technology. This product is for the oil and gas sector for ROVs.

Kraken Robotics also has its Kraken SeaVision™ system. This is an inventive new take on subsea 3D laser imaging. The design of it is to operate in a twin scanning configuration, with adjustable baseline. SeaVision can produce very high resolution 3D scans in full color.

Additionally, the Company has its DataPod™ product. The design of it is to meet modern data storage requirements for rugged marine applications. DataPod™ combines the user-friendliness of a Network Attached Storage system with the reliability of a RAID array and solid state storage all in one compact unit.

The Company’s Kraken Robotic Systems subsidiary has entered a strategic partnership with Avitas Systems, a GE Venture. The companies will integrate Autonomous Underwater Vehicles (AUVs), acoustic and laser sensor technology and artificial intelligence-based navigation software into innovative subsea inspection solutions for the oil and gas, offshore renewable energy, and shipping industries.

In January, Kraken Robotics announced that its German subsidiary, Kraken Robotik GmbH, was named a winner in the Carbon Trust's Offshore Wind Accelerator (OWA) competition. The OWA is a collaborative research and development (R&D) program funded by nine top offshore wind developers and the Scottish Government to lessen the cost of offshore wind energy. Kraken Robotik was one of only four companies selected in the competition.

At the end of January, Kraken Robotics announced that its wholly-owned subsidiary, Kraken Robotic Systems, Inc., was awarded a repeat contract valued at more than C$400,000 by a foremost military customer for its AquaPix® Miniature Synthetic Aperture Sonar system. Because of the confidential nature of the application, the customer's name is not disclosed. The expectation is that delivery will be in Q2 2018.

Kraken Robotics, Inc. (KRKNF), closed Thursday's trading session at $0.1279, down 0.85%, on 208,229 volume with 21 trades. The average volume for the last 60 days is 65,853 and the stock's 52-week low/high is $0.10/$0.20.

PwrCor, Inc. (PWCO)

Amigo Bulls, Stockhouse, Barchart, InvestorsHub, MarketWatch, OTC Markets, and Stockopedia reported on PwrCor, Inc. (PWCO), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, PwrCor, Inc is a clean technology energy technology company. It is launching advanced and disruptive solutions for the Waste Heat to Energy, Geothermal, and Solar Thermal markets, and other applicable markets. In addition, PwrCor centers on energy infrastructure development projects and delivering cleantech energy solutions to commercial and not-for-profit customers. PwrCor is headquartered in New York, New York.

The Company also identifies, selects, and implements cost-effective and sustainable energy production technologies for its customers. It assists in different ways to finance those improvements. The PwrCor™ engines use proprietary technology, which can cost effectively convert ultra-low-grade heat to usable mechanical or electrical energy.

PwrCor™ utilizes no fossil fuels. It does not operate by way of combustion. It has no emissions, and does not process any working fluids that are flammable, harmful to the environment, or expensive to replace.

PwrCor™ is scalable and modular. Furthermore, it runs relatively silently, all within a small footprint.

PwrCor has commenced a program with Consolidated Edison, Inc. to develop a pilot project based on its proprietary PwrCor™ engine technology. The program is founded on PwrCor’s advanced green waste-heat-to-power technology in an application that captures waste steam condensate and converts it to electricity before it is disposed of in the municipal sewer system. The structure of the program is to culminate in a Pilot Project installation of a PwrCor engine at a suitable Con Ed customer site.

PwrCor’s proprietary technology can operate in the entire range of temperatures. Nonetheless, the Company expects to rapidly capture market share through expanding the market into lower temperature resources.

PwrCor can make a customer’s power generation more efficient. The Company can assist them in tapping renewable energy sources, therefore qualifying them as providing renewable energy.

Last month, PwrCor announced that the manufacture, initial testing, and trial runs of its first engine have been completed successfully. This engine is built to operate using ultra-low-grade heat from a geothermal source.

This marks a significant milestone to provide clean, “green” electrical power to the Surprise Valley Hot Springs Resort in Modoc County, California. The engine was designed and constructed at Southwest Research Institute in San Antonio, Texas. It is the first of its type that deploys PwrCor’s proprietary technology.

PwrCor, Inc. (PWCO), closed Thursday's trading session at $0.20, down 13.01%, on 116,859 volume with 35 trades. The average volume for the last 60 days is 58,795 and the stock's 52-week low/high is $0.0551/$0.51.

theMaven, Inc. (MVEN)

InvestorsHub and Stockhouse reported on theMaven, Inc. (MVEN), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, theMaven, Inc. is an expert-driven, group media network. The Company’s advanced platform serves, by invitation-only, an alliance of professional, independent channel partners. theMaven’s Executive team and operational Board members include digital media pioneers Mr. James Heckman and Mr. Ross Levinsohn, as well as technology innovators Mr. Bill Sornsin and Mr. Ben Joldersma. A digital media start-up, theMaven has its head office in Seattle, Washington.

The Company provides elite content leaders an end-to-end digital platform within a cooperative that shares resources and distribution and maximizes monetization. theMaven enables partners to concentrate on the vital drivers of their businesses - creating, informing, sharing, discovering, leading, and interacting with the communities and constituencies they serve.

theMaven enables partners to do so through providing wider distribution, more community engagement, and efficient advertising and membership programs. During Q2 2017, theMaven focused on three key strategic initiatives - developing its technology platform, business development to sign new Mavens to its network, and launching operations with certain Mavens.

On January 5, 2018, Maven announced that it agreed to acquire HubPages in a union that will bring together over 40 million monthly unique users together in a single premium digital media network, the two companies announced after signing a letter of intent (LOI). The expectation is that this transaction will close within 90 days.

HubPages’ network will undergo migration to Maven’s publishing and community platform, relaunched as part of a single premium network, on one platform for advertisers. The expectation is that moving the network to Maven will improve traffic, engagement, as well as monetization.

Migration of the 27 premium channels to Maven’s platform will happen one at a time, over the next year, subsequent to testing and developing the migration plan. HubPages will remain a vital “cultivating” network, at HubPages.com.

At the end of January, Maven announced it is partnering with Po.et to provide Maven’s content creators protection from improper use of their content and ensure fair monetization. Po.et is a blockchain-based open universal ledger for digital creative assets.

Using cryptography, Po.et gives content creators and publishers the tools to automate the licensing process without relying on third parties. Po.et will provide Maven publishers with the ability to timestamp and validate their content and digital assets in an unchangeable system that will automatically issue digital ownership certificates.

This month, Maven announced that Mr. Josh Jacobs, former Omnicom and Yahoo! senior executive, was named President and Executive Chairman of Maven after joining originally as a consultant and serving as Maven’s Co-Chair over the last year. Mr. Jacobs is an innovator in digital advertising, on the demand and supply sides, and a major media veteran with senior executive roles at Glam, Yahoo!, as well as Omnicom.

theMaven, Inc. (MVEN), closed Thursday's trading session at $1.65, down 5.71%, on 37,549 volume with 35 trades. The average volume for the last 60 days is 28,458 and the stock's 52-week low/high is $1.00/$2.573.

MPX Bioceutical Corporation (MPXEF)

OTC Markets, OTC Dynamics, Jet Life Penny Stocks, TalkMarkets, Barchart, Investing News Alerts, Penny Stock Hub, Stockhouse, MarketWatch, InvestorsHub, Stockwatch, Investorx.ca, 4-Traders, TradingView, and High Rising Stocks reported on MPX Bioceutical Corporation (MPXEF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

MPX Bioceutical Corporation, via its wholly-owned subsidiaries in the United States, provides considerable management, staffing, procurement, advisory, financial, real estate rental, logistics and administrative services to two medicinal cannabis enterprises in Arizona. These businesses operate under the Health for Life (dispensaries) and the award-winning Melting Point Extracts (high-margin concentrates wholesale) brands. MPX also has operations in the State of Massachusetts.

MPX Bioceutical has its corporate headquarters in Toronto, Ontario. The Company previously went by the name The Canadian Bioceutical Corporation. It changed its name to MPX Bioceutical Corporation in November of 2017. The Company lists on the OTC Markets Group’s OTCQB.

MPX Bioceutical is a multi-state diversified cannabis company. It has operations focused in the United States in the adult use and medical cannabis markets. The Company has completed its agreement to acquire GreenMart operations in Nevada. Furthermore, it signed non-binding Letters of Intent (LOI) to purchase dispensary and production licenses in Maryland. In addition, MPX has applied for a license in Canada.

Furthermore, regarding Pharma-grade products, MPX Bioceutical signed a definitive agreement to establish a joint venture (JV) with Panaxia. This JV is to develop proprietary, smokeless pharma-grade products using cannabis. MPX’s corporate mission is to become a foremost commercial producer of medical marijuana and pharma-grade products in North America.

Last month, MPX Bioceutical announced that it, via its indirect wholly-owned subsidiary, S8 Management, is entering into management agreements with each of Rosebud Organics, Inc., which is authorized to purchase, process and sell medical cannabis products in Maryland, and Budding Rose, Inc., which is authorized to operate a dispensary and sell medical cannabis products in Maryland. With the management agreements, S8 Management will provide all management services normally required by a production facility, in the case of Rosebud, and a dispensary facility, in the case of Budding Rose.

Further to managing the facilities, MPX Bioceutical, via its wholly-owned subsidiary, CGX Life Sciences, Inc., will at the same time acquire options to purchase 100 percent of the issued and outstanding common stock of Rosebud for aggregate consideration of US$3,018,181.82, and Budding Rose for aggregate consideration of US$2,481,818.18.

This month, MPX Bioceutical announced the Company’s inclusion in the newly created Horizons Emerging Marijuana Growers Index ETF. As Horizon’s second marijuana focused fund, the design of the Index is to provide exposure to the performance of a basket of mainly North American publicly-listed small capitalization companies engaged in the cultivation, production and/or distribution of marijuana.

MPX Bioceutical Corporation (MPXEF), closed Thursday's trading session at $0.576, up 2.45%, on 106,638 volume with 83 trades. The average volume for the last 60 days is 1,150,949 and the stock's 52-week low/high is $0.2257/$0.99.

Asia Equity Exchange Group, Inc. (AEEX)

OTC Markets, InvestorsHub, and MarketWatch reported on Asia Equity Exchange Group, Inc. (AEEX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Asia Equity Exchange Group, Inc. is working to establish and build an equity information service platform designed to provide equity investment financing information to all enterprises in the nations and regions of Asia. Asia Equity Exchange Group, with its website www.asiaotcmarkets.com, invested and operated by Asian Equity Exchange Group Co., Ltd., is an intercontinental equity exchange and a service platform for companies in Asia to release equity investment and financing information.

Asia Equity Exchange Group has offices in Kowloon Bay, Hong Kong; Shenzhen, China; and New York, New York. The Company lists on the OTC Markets Group’s OTCQB.

The operating structure of the Company is: Asia Equity Exchange Group, Inc. 100 percent shareholding Asian Equity Exchange Group Co. Ltd. 100 percent shareholding AEEX (HK) International Financial Services Limited 100 percent shareholding Asian & American Consultant (Shenzhen) Co. Ltd.

In essence, Asia Equity Exchange Group integrates worldwide capital and works with providers of a broad array of services. The Company provides growing and innovative companies with diversified and professional services, and global professional investors with quality, open, and diverse investment opportunities. It serves as a significant part and a vital link of the multi-layered capital markets in Asia. Asia Equity Exchange Group enables companies to obtain the resources to successfully launch their IPO (Initial Public Offering).

Asia Equity Exchange Group helps companies develop in a sustainable manner. Furthermore, the Company introduces high-value investment markets to professional institutional and individual investors.

In addition, it aims to create a unique and authoritative intercontinental equity information platform, which effectively complements business functions, service means and financing channels with OTC markets in different nations and regions.

Asia Equity Exchange Group is also working to build a system of intercontinental cooperation to provide listed enterprises with equity financing means through domestic and out of the country channels, and to provide nurturing, pre-listing tutoring, and incubating, and also supporting services for their listing on overseas capital markets by shifting boards.

Asia Equity Exchange Group introduces global securities and institutional investors in its shareholder structure. Moreover, it partners with international organizations in its operations. These include investment banks, financial and legal institutions, and professional consulting teams.

In December, Asia Equity Exchange Group hosted a media event at the Hilton Shenzhen Futian, announcing the successful financing of $15 million USD for a private placement deal. The AEEX management team and guest speakers examined the development of the private placement process and discussed how Chinese SMEs (small and medium sized enterprises) can develop faster and more effective methods to operate in capital markets.

Asia Equity Exchange Group, Inc. (AEEX), closed Thursday's trading session at $5.35, up 1.90%, on 2,200 volume with 6 trades. The average volume for the last 60 days is 3,252 and the stock's 52-week low/high is $4.63/$21.11.

Santa Fe Gold Corporation (SFEG)

OTC Markets, Zacks, 4-Traders, InvestorsHub, MarketWatch, The Street, Investopedia, Stockflare, StreetInsider, and Stockhouse reported on Santa Fe Gold Corporation (SFEG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Established in 1991, Santa Fe Gold Corporation’s intention is to establish itself as a significant player in the precious metals mining field. Its objective is to produce substantial cash flow from precious metals holdings. This is while creating a portfolio of high quality exploration and bankable development projects that will ensure future revenue growth. OTCQB-listed, Santa Fe Gold is headquartered in Albuquerque, New Mexico.

The Company’s focus is on Gold, Silver, and Copper, Precious, Industrial and Base metals. Santa Fe Gold’s assets include the Knight’s Peak region of Grant County, New Mexico consisting of the Malone Mines, Patanka, Hillcrest Barranca and Principal Mines, altogether incorporating about 20 mine sites and all situated at Knight’s Peak, together with an expanded area surrounding the Malone Mines in the southern area of Burro Mountains, New Mexico.

In addition, Santa Fe Gold owns very significant holdings in the Playas Lake Bed Area of Hidalgo County. This includes the presences of Titanium ore and other rare earth minerals and deposits.

At the end of November 2017, Santa Fe Gold announced that preparations were underway to start mining production as soon as possible upon completion of the acquisitions and final permitting. Santa Fe is in the closing stage of acquisition of 100 percent of Bullard’s Peak Corporation and Black Hawk Consolidated Mines Company.

The acquisitions include the previously optioned AG1 Silver Mine and all lands surrounding the project. This includes a potential Porphyry Silver Discovery, Cobalt, and Lithium, Manganese and Nickel and all rights to same.

In late December, Santa Fe Gold announced it received an additional US$849,958.17 with more funding expected from International Investment Group and its associated investors, bringing their overall stake in Santa Fe Gold to in excess of $6 Million converted to equity at prices close to recent market quotes.

The Company expects to complete 100 percent of the purchase of Silver Mines: Bullard's Peak Corporation and Black Hawk Consolidated Mines in the opening days of 2018. The expectation is that production will commence in the interim afterward. Furthermore, Santa Fe Gold expects to announce at least four new acquisitions in Q1 of 2018.

Santa Fe Gold President and Chief Executive Officer, Mr. Tom Laws, said in December, "We are delighted with the increased investment in Santa Fe Gold which demonstrates confidence in our ongoing near term plans. We expect to close on the AG1 Silver Mines early in the New Year as well as being able to give additional details on why we are really excited about this and other new acquisitions."

Santa Fe Gold Corporation (SFEG), closed Thursday's trading session at $0.139, up 1.61%, on 75,356 volume with 18 trades. The average volume for the last 60 days is 117,942 and the stock's 52-week low/high is $0.056/$0.2323.

Primero Mining Corp. (PPPMF)

Zacks, Stockhouse, and Business Insider reported on Primero Mining Corp. (PPPMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A precious metals producer, Primero Mining Corp. is a gold mining company that owns the San Dimas gold-silver mine in Mexico (100 percent owned). The Company’s total concession area in the San Dimas district totals 68,628 hectares. Primero’s emphasis is on becoming a foremost intermediate gold producer through building a portfolio of high quality, low cost precious metals assets in the Americas. Primero Mining has its corporate office in Toronto, Ontario. The Company lists on the OTC Markets Group’s OTCQB.

Primero Mining acquired the San Dimas mine in August of 2010. The San Dimas mine is roughly 125 kilometers northeast of Mazatlán, on the border of Sinaloa and Durango States, in central west Mexico. The San Dimas mine comprises five ore zones or blocks: Central, Sinaloa Graben, Tayoltita, and Arana Hanging Wall, and San Antonio West. These are contained within a 22,500 hectares contiguous property.

The Company uses long-hole stoping and mechanized cut-and-fill underground mining methods. All mined production undergoes processing at the Tayoltita mill. The San Dimas deposit is considered to be one of the most significant precious metal deposits in Mexico, positioned within a very large (15 square kilometers) mining district.

Historic production from the San Dimas district has been estimated to total 11 million ounces of gold and 582 million ounces of silver. The Tayoltita mill has a nameplate capacity of 2,500 tonnes per day.

Regarding its exploration properties, Primero Ming has its Ventanas and Lechuguilla concessions. These are adjacent and to the south of the San Dimas mine, in the southern part of the San Dimas District. The Company owns 100 percent of the Ventanas and Lechuguilla properties.

The Ventanas property is 32 kilometers southeast of San Dimas. It totals 3,470 hectares. Ventanas contains no less than 17 old mine workings and multiple low to intermediate sulphidation epithermal veins systems. Numerous parts of the Ventanas property remain under-explored.

The Lechuguilla Greenfield property is directly adjacent to the south of San Dimas. Lechuguilla is largely unexplored because of its huge size and the region's challenging topography.

Primero Mining Corp. (PPPMF), closed Thursday's trading session at $0.1734, up 4.33%, on 14,024 volume with 12 trades. The average volume for the last 60 days is 401,164 and the stock's 52-week low/high is $0.06/$0.699.

graphic

The QualityStocks
Company Corner

graphic
graphic

PotNetwork Holdings Inc. (POTN)

The QualityStocks Daily Newsletter would like to spotlight PotNetwork Holdings Inc. (POTN). Today, PotNetwork Holdings Inc. closed trading at $0.561, up 12.16%, on 8,968,591 volume with 2,392 trades. The stock’s average daily volume over the past 60 days is 13,612,950, and its 52-week low/high is $0.0006/$0.957.

PotNetwork Holdings Inc. (POTN), based in Fort Lauderdale, Florida, is a holding company. The company's First Capital Venture Co. subsidiary is the owner of Diamond CBD, Inc., a producer of widely-distributed CBD hemp extracts and the primary operating entity of PotNetwork Holdings.

Diamond CBD is made up of chemists and other scientists focused on developing and producing very high-quality CBD oil over a broad range of products, based upon a thorough understanding of the various natural molecules found in hemp and their particular properties. All products are made with federally legal cannabidiol (CBD), and are available in hundreds of flavors and sizes. The company emphasizes a dedication to 100% natural lab-tested CBD ingredients, with a carefully monitored process all the way from the source farm, through production, and final delivery to retail shelves.

PotNetwork, through Diamond CBD, delivers products to all 50 states, as well as internationally, and controls 15 CBD brands. The company lists the following product brands:

  • Diamond CBD Gummies - Diamond CBD branded edible gummies made from crystal isolate. Available in a variety of flavors and gummy styles, including rainbow bites, mini fruit, gummy worms, sour snakes, and more.
  • Chill Gummies - Chill gummies are more robust than its counterpart, the "Relax" gummy line. Chill Gummies are edible CBD gummies available in a wide variety of flavors, strengths, and styles including gummy bears, sour snakes, rainbow bites, watermelon slices, sour snakes, rainbow bites, peanut butter chocolate, ocean gummies, gummy worms, gummy rings and more.
  • CBD Liquid Gold - CBD Liquid Gold is derived from naturally grown industrial hemp plants, certified by USA labs and then carefully mixed with a patent-pending (non-PG) all-natural base formulation.
  • Blue CBD - Blue CBD Crystal Isolate is a high-end vapor liquid and oral drop infused with premium CBD rich hemp oil. CBD liquids are Premium Gold quality and test at a 7X higher concentration.
  • Relax Gummies - Relax Gummies give a lighter effect of CBD with some natural flavors in comparison to its counterpart Chill Gummies. Relax Gummies are perfect for anyone with a sweet tooth that's looking for a lighter effect without sacrificing quality or taste.
  • Premium Hemp Liquid Pet - CBD For Pets is a new and refreshing product from Diamond CBD for all the millions of pets out there. It is an organic product and also has unique flavors in it.
  • CBD Re-Leaf - Disposable, long-lasting, and ready to Use CBD Re-leaf vaping pens available in a variety of flavors. Easily take CBD anywhere on the go.
  • Relax Extreme CBD - Relax Extreme CBD Oil provides a high-quality, high-strength dose of CBD through oral drops. It is very easy to use and works instantly. Simply place a drop under the tongue. Available in various strengths.
  • CBD Double Shot - CBD Double Shots are specifically designed for one-time use. Easily squeeze the package in your mouth and swallow; it's that simple. Take it anywhere you go. Relaxation is now conveniently in your pocket. Drinkable CBD shots provide a quick boost of relaxation on the go. Available in various flavors.
  • Chill Pill - CBD infused capsules available in various strengths. Relax, take a Chill Pill.

Over 1.2 million people currently use cannabis, including CBD products, for medical application, including cancer, epilepsy, and depression. By sourcing hemp outside the U.S., the company avoids current federally-based legal problems involved in growing cannabis domestically. In the meantime, PotNetwork Holdings continues to target a large and rapidly developing cannabis market, expanding from $6.5 billion in 2016, to an expected $30 billion in 2021 (Forbes), and $50 billion in 2026 (Bloomberg). The cannabidiol market alone is projected to reach $2.1 billion in 2020, a 700% increase from 2015. PotNetwork Holdings Inc. plans to expand its subsidiaries as well as make strategic acquisitions. Disclaimer

PotNetwork Holdings Inc. Company Blog

PotNetwork Holdings Inc. News:

With $756,000 in Sales, PotNetwork Holding, Inc. Continues Strong Upward Trend, Reporting Revenues over 360% Higher Than Corresponding 2017 Timeframe

PotNetwork Holding’s Diamond CBD Showcases Expanded Product Line at CHAMPS Winter Show at Las Vegas Convention Center

PotNetwork Holding Successfully Launches Meds BioTech Line into New Industry Sector

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.0256, up 0.79%, on 3,414,670 volume with 214 trades. The stock’s average daily volume over the past 60 days is 15,898,189, and its 52-week low/high is $0.0141/$0.16.

Global Payout, Inc. (OTCPink:GOHE) ("Global") is pleased to announce that the CEO of its majority owned subsidiary, MoneyTrac Technology, Inc. ("MTRAC", the "Company"), Vanessa Luna has opted on her own accord to indefinitely suspend her salary effective March 1, 2018. Also today, CannabisNewsWire released a report explaining how the multiple, increasingly interwoven verticals now present in the booming cannabis industry run the gamut. However, payment solutions, such as those offered by Global Payout, Inc., represent some of the most high-potential integrations.

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout's fully configurable "banking-in-a-box" web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today's banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout's management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and "high-risk" market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and "high-risk" enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

Preparing for Growth: MoneyTrac Technology CEO Suspends Salary to Accelerate Expansion in 2018

The Modern Cannabis Industry — A Tight Mesh of Integrated Verticals and Technologies

MoneyTrac Technology, Inc. Appoints New Director of Business Development in Preparation for Expansion in 2018

Petroteq Energy Inc. (TSX.V:PQE) (OTCQX:PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF). Today, Petroteq Energy Inc. closed trading at $1.14, up 0.70%, on 62,379 volume with 76 trades. The stock’s average daily volume over the past 60 days is 83,831, and its 52-week low/high is $0.015/$1.8892.

Petroteq Energy Inc. (TSXV: PQE; OTCQX: PQEFF; Frankfurt: A2DYWC), a company focused on the development and implementation of proprietary technologies for the energy industry, today announced that it has completed improvements to its Asphalt Ridge Utah Plant that will expand capacity to 1000 bpd (barrels per day).

Petroteq Energy Inc. (TSX.V: PQE) (OTCQB: PQEFF), with headquarters in Canada, seeks to create the world's largest pure-play cobalt exploration and development company. The company's current focus is on its Greater Cobalt Project located in Silver Centre, Ontario. The company is also in the midst of a three-way merger with Cobalt One Ltd. and CobalTech Mining Inc. and on completion First Cobalt will control over 10,000 hectares of prospective land and 50 historic mining operations in the Cobalt Camp in Ontario, Canada, as well as a mill and a permitted refinery facility.

The merger agreements with Cobalt One Ltd. and CobalTech Mining Inc., announced earlier this year, will result in a combined land position of more than 10,000 hectares (nearly 25,000 acres) in the Cobalt Camp containing approximately 50 past cobalt/silver producers and working mines. Initial test results from a mineralogical assessment of sample material taken from various historical mines located throughout the Cobalt Camp show both cobalt-rich and silver-rich mineralization styles. Samples taken at the former Bellellen mine, located within the Greater Cobalt Project in Ontario, show high grade cobalt assays, prompting First Cobalt to increase its drilling program at that site.

Petroteq Energy Inc. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world's current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

The company's clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, Petroteq Energy Inc. and its mining interests are primed for success.

Petroteq Energy Inc. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance. Disclaimer

Petroteq Energy Inc. Company Blog

Petroteq Energy Inc. News:

Petroteq Energy Announces Completion of Facility Improvements Bringing Production Capacity to 1000 Barrels Per Day

Petroteq Energy’s (TSX.V: PQE) (OTCQX: PQEFF) Blockchain Platform Taking Sharing Economy to Oil & Gas Industry

Petroteq Energy Announces Development of PetroBLOQ Payments

First Cobalt Corp. (TSX.V:FCC) (OTCQB:FTSSF)

The QualityStocks Daily Newsletter would like to spotlight First Cobalt Corp. (FTSSF). Today, First Cobalt Corp. closed trading at $0.8772, up 3.20%, on 317,140 volume with 235 trades. The stock’s average daily volume over the past 60 days is 293,539, and its 52-week low/high is $0.3148/$1.3041.

Cobalt exploration and development company First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF) this morning announced that it has been named as one of the top performing mining companies in the TSX Venture 50™. Also today, NetworkNewsWire released a report explaining how the need for cobalt in the manufacture of green car batteries has fueled staggering growth for First Cobalt, with a share price increase of as much as 350 percent in a single year.

First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF), with headquarters in Canada, is the largest land owner in the Cobalt Camp in Ontario with control of over 10,000 hectares (nearly 25,000 acres) of prospective land and 50 historic cobalt/silver mines. The company’s assets include a mill and the only permitted cobalt extraction refinery in North America capable of producing battery material, providing an integrated solution for cobalt projects. First Cobalt began drilling in the historic Cobalt Camp in 2017 and seeks to build shareholder value through new discovery and growth opportunities.

First Cobalt’s 2018 $C7 million drilling program, which includes testing different styles of mineralized areas throughout the Cobalt Camp in more than 10 past-producing mines known to contain cobalt, is a significant expansion over its 2017 exploration activities. The company received positive test drill results from the Bellellen mine location, with early results confirming the presence of high-grade cobalt and nickel, prompting First Cobalt to increase its drilling program at that site. A prospecting sampling program of existing muckpiles around the camp’s historic mines, trenches, pits and surrounding bedrock could provide an early production scenario.

First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world’s current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

First Cobalt is embracing innovation in the mining sector, utilizing a digital compilation of 100-plus years of mining and geological data spanning the historically prolific Cobalt Mining Camp’s lifespan. First Cobalt’s management team is also assessing the ability of artificial intelligence to accelerate the discovery cycle. As a member of the Mineral Exploration Research Centre (MERC) and Metal Earth Project, First Cobalt conducts regional geophysical surveys for geological interpretation of structures controlling cobalt-silver mineralization.

The company’s clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.

First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance. Disclaimer

First Cobalt Corp. Company Blog

First Cobalt Corp. News:

NetworkNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF) Recognized as Top Mining Firm in TSX Venture 50™

Rise of Electric Cars Fuels Cobalt Market Surge

First Cobalt Begins Drilling in Cobalt North

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P)

The QualityStocks Daily Newsletter would like to spotlight Liberty Leaf Holdings Ltd. (LIBFF). Today, Liberty Leaf Holdings Ltd. closed trading at $0.3797, off by 1.09%, on 28,951 volume with 14 trades. The stock’s average daily volume over the past 60 days is 199,186, and its 52-week low/high is $0.0091/$0.8074.

Liberty Leaf Holdings Ltd. (CSE: LIB, OTCQB: LIBFF and FSE: HN3P) and Blox Labs Inc. (CSE: BLOX) are pleased to provide an update regarding the initial Phase 1 development of "cannaBLOX", a Blockchain-based smart contract supply chain management platform for the legalized cannabis industry that is being developed in partnership. 

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF), is a publicly traded Canadian-based company with strategic investments in businesses that are established, revenue- producing players in the medicinal and recreational cannabis market. Liberty Leaf’s focus is to build and support a diversified portfolio of cannabis-sector businesses, including those involved in the cultivation and processing of legal medicinal and recreational cannabis, value-added CBD/THC pet products, and supply-chain products for this dynamic and fast-growing sector. Liberty Leaf provides funding, management, HR resources and marketing expertise to help companies thrive and accelerate growth.

Liberty Leaf’s leading investments to date include:

  • North Road Ventures – An emerging end-to-end distributor of cultivated and manufactured cannabis products to licensed legal retailers. North Road has updated its application for an Access to Cannabis for Medical Purposes Regulations (ACMPR) license to be distribution/sales-focused, making the company unique in the crowded field of other cultivation-based applicants. This forward-thinking initiative will help fulfill the anticipated increase in Canada’s recreational cannabis space once legalization takes effect in mid-2018. The submission includes a boost in product-vault capacity that will result in a five-fold increase in products available for distribution. Cannabidiol (CBD)-oil products are expected to account for 50 percent or more of projected sales.
  • Just Kush Enterprises – Liberty Leaf holds a 60 percent interest in Just Kush, a cultivator of premium, proprietary cannabis strains selected for different levels of CBDs and THCs. Just Kush’s cultivation facility is located near Oliver, British Columbia, and it currently controls a facility which holds a Medical Marihuana Access Regulations (MMAR) license. The company is also a late-stage applicant for an ACMPR license (Access to Cannabis for Medical Purposes Regulations), which will enable Just Kush to produce cannabis for the medicinal and recreational market.

Liberty Leaf is also an active partner with the following companies:

  • ESEV R&D – A privately owned, medical marijuana research and development company based in New York with clinical laboratories located in Israel. ESEV R&D, in collaboration with a leading clinical research organization in Israel, has launched a one-of-a-kind service for North American medical cannabis companies to organize and oversee clinical trials seeking to demonstrate the efficacy of medical cannabis products for specific medical conditions. Liberty Leaf has a three-year collaborative agreement with ESEV. Under that agreement, ESEV is researching the efficacy of CBDs in pets, with the 1st formulation trial targeting canine osteoarthritis, a medical condition that includes: hip dysplasia; elbow dysplasia; and hind-knee, also known as stifle, degenerative joint disease (DJD).
  • Blox Labs Inc. – A boutique technology company focused on creating best-in-class smartphone apps and software solutions driven by emerging trends in blockchain, smart contracts and decentralized application technologies. Liberty Leaf and Blox Labs are developing “cannaBLOX,” a blockchain-based smart contract supply chain management platform for the legalized cannabis industry.

The company’s management team is led by President and Director William Rascan who has 25-plus years in the investment brokerage industry, most recently as a partner, senior investment advisor with Northern Securities. Rascan’s business experience ranges from active international trading clients to raising capital for junior mining companies on the TSX Venture Exchange.

Rascan is joined by CFO Jamie Robinson, a chartered accountant who specializes in accounting, auditing, and financial reporting under both IFRS and ASPE. Prior to joining Liberty Leaf, Robinson worked at Deloitte as a manager focused on publicly listed and private company audits, business review, performance enhancement engagements and restructuring proceedings.

Steven Feldman, who has more than 25 years of experience in the capital markets and was part of the original management team of SouthGobi Resources; and Doug Macdonell, a retired RCMP officer and recognized expert in the field of cannabis and cultivation, serve as company directors. Dr. Robert Jackman, who has worked closely with multiple clients in the medical cannabis and Natural and Non-prescription Health Products (NNHP) industries in North America, was recently appointed as scientific project manager/fulfillment.

Liberty Leaf’s advisory board includes international lawyer, writer and speaker Robert W.E. Laurie; Barinder Rasode, who currently serves as CEO of the National Institute for Cannabis Health & Education (NICHE); and Dr. Mary C. Fitzpatrick, B.S., D.V.M., whose primary focus is on helping companion animals live pain free in their senior years. Disclaimer

Liberty Leaf Holdings Ltd. Company Blog

Liberty Leaf Holdings Ltd. News:

Liberty Leaf Holdings and Blox Labs Provide Update on Cannabis Blockchain Project "cannaBLOX"

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) is “One to Watch”

Liberty Leaf and North Road Ventures Welcome BC Retail Guidelines for Cannabis

AnalytixInsight Inc. (TSX.V:ALY) (OTCQB:ATIXF)

The QualityStocks Daily Newsletter would like to spotlight AnalytixInsight Inc. (ATIXF). Today, AnalytixInsight Inc. closed trading at $0.3669, off by 1.21%, on 1,320 volume with 7 trades. The stock’s average daily volume over the past 60 days is 36,275 and its 52-week low/high is $0.15/$0.6898.

Artificial Intelligence company, AnalytixInsight Inc. (TSX-V:ALY) (OTCQB:ATIXF) is pleased to announce that it has been named as one of the top 10 performing technology companies in the TSX Venture 50™, a recognition of top performers on the TSX Venture Exchange during 2017.

AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) is an artificial intelligence (AI) company that transforms data into knowledge. The company has developed a proprietary, machine-learning technology that algorithmically analyzes big data and distills it into actionable insights. AnalytixInsight has strategic initiatives in fintech, blockchain and workflow analytics, and its technology is scalable and extendable to virtually any data-driven industry such as sports, communications, healthcare, insurance or government.

The company's flagship product – CapitalCube.com – is a financial portal providing comprehensive company analysis including on-demand fundamental research, portfolio evaluation and screening tools on over 50,000 global equities and North American ETFs. CapitalCube's online portal is designed to empower investment ideas by providing in-depth analysis, peer-to-peer performance evaluations, accounting and earnings reports, dividend strength and AI-supported information about likely corporate actions such as dividend changes, share buybacks and acquisitions. AnalytixInsight provides a robust technology that is frequently rebalanced to maintain a desired risk profile, matching risk to ideal ETF exposure, with regular compliance reporting.

CapitalCube's freemium pricing model allows free access to basic financial information, with additional in-depth analysis and predictive analytics provided at a rate of $25 per month, and customized peer analysis for $300 per month. CapitalCube publishes 3,000 articles daily and has multi-language capabilities. Thomson Reuters and Africa Investor have recently been added to the growing network of content partnerships that already includes Euronext NV, Yahoo Finance and The Wall Street Journal.

Euclides Technologies is a subsidiary company focused on Field Service Management software solutions, led by a team with decades of experience in developing and implementing workforce management solutions for large global corporations. With worldwide customers representing over 100,000 field service personnel across multiple industries, Euclides Technologies has a deep understanding of the increasing amount of data generated within the industry, as well as the analytics solution offerings to transform that data into knowledge.

MarketWall is a Fintech subsidiary that develops integrated software solutions as part of an ecosystem of smart devices that includes PCs, tablets, smart phones, wearable mobile devices and Smart TV. AnalytixInsight Inc. has joint ownership in MarketWall together with Intesa Sanpaolo, Italy's largest retail bank which has over 4,000 branches and a market capitalization of $40 billion Euros. MarketWall is expected to deploy its real-time stock trading and mobile banking app to Intesa Sanpaolo's 12.6 million customers in six European countries during 2018. The mobile stock trading application will directly interface with Intesa Sanpaolo's established MarketHub trading platform. As a Samsung Global Partner, the MarketWall app is preloaded in mobile devices in certain areas in Europe.

AnalytixInsight is currently evaluating and pursuing Blockchain initiatives which are contiguous with its artificial intelligence platform, to use a distributed ledger technology to reduce transaction costs and settlement times for its users, partners, and subsidiaries. The Company believes these initiatives will enhance current revenues being received from existing multi-year agreements with its partners. Disclaimer

AnalytixInsight Inc. Blog

AnalytixInsight Inc. News:

AnalytixInsight Named a Top 10 Technology Company on the TSX Venture 50™

NetworkNewsBreaks – AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) Offers In-depth Analysis, Predictive Analytics with CapitalCube Online Portal

AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) Uses AI to Enable Critical Decisions

MGX Minerals Inc. (MGXMF)

The QualityStocks Daily Newsletter would like to spotlight MGX Minerals Inc. (MGXMF). Today, MGX Minerals Inc. closed trading at $1.2097, off by 1.59%, on 179,623 volume with 90 trades. The stock’s average daily volume over the past 60 days is 290,613 and its 52-week low/high is $0.543/$1.5835.

MGX Minerals Inc. (CSE:XMG) (FKT:1MG) (OTCQB:MGXMF) is pleased to report that joint venture partner Power Metals Corp. (“Power Metals”) has completed a 30-hole, 3,000 metre diamond drill program on the Northeast Dyke at its Case Lake Property near Cochrane, Ontario. 

MGX Minerals Inc. (CSE: XMG) (FKT: 1MG) (OTCQB: MGXMF) is a diversified Canadian resource company developing large-scale mineral portfolios in specific commodities and jurisdictions in North America. The company controls significant interest in lithium, magnesium and silicon assets that offer streamlined development timelines and low capital expenditures. MGX Minerals and its engineering partner have developed a patent-pending, low-energy design process to extract valuable minerals from the abundant, highly mineralized brine wastewater produced each year by oil and gas companies.

This proprietary, petrolithium process rapidly concentrates lithium and other minerals from brine in less than a day. That's a stunning advancement from the conventional method of extracting minerals from brine through an evaporation process that can take up to 18 months, requires hundreds of acres of land, and averages less than a 50 percent mineral recovery rate. Using this advanced water purification technology, MGX Minerals cleans the wastewater that accompanies petroleum as it's being pulled up to the surface. The company's petrolithium process eliminates the need to inject contaminated wastewater back into the ground, which prevents drinking water contamination and possible earthquakes.

In January 2017, MGX Minerals successfully recovered concentrated lithium from heavy oil evaporator blowdown wastewater using its rapid recovery process, an accomplishment independently confirmed by the Saskatchewan Research Council. In August 2017, the company also successfully processed wastewater and lithium brine from eight North American projects at its one-cubic-meter-per-hour processing plant, proving the technology is economically viable. Research group Global Water Intelligence expects the wastewater treatment industry to grow into a $45 billion market annually by 2025, which suggests there are ample revenue-generating opportunities for MGX Minerals technology.

Lithium, the "white gold" of the new energy economy, is the key to clean energy development as global demand for hybrid and electric vehicles, high-drain portable electronic devices, and large-scale energy storage systems ramps up. Grand View Research, Inc. reports that the global lithium-ion battery market is expected to reach $93.1 billion by 2025. Current market forces show a high demand for lithium and a low supply, which further supports the necessity of MGX Mineral's cleaner, faster method of extracting high-value minerals from brine wastewater.

MGX Minerals is led by a team of industry standout performers who have worked in the mining and technology industries for decades. The leadership team is joined by an array of top-notch technical partners with unmatched experience in the oil and gas sectors, environmental services industry, marketing and product development, along with applied research and commercial development of technologies. Disclaimer

MGX Minerals Inc. Blog

MGX Minerals Inc. News:

MGX Minerals Announces Completion of 3,000 Metre Drill Program at Case Lake Lithium; 8,000 Metre Spring Drill Program Planned

MGX Minerals Commences Lithium Brine Testing in Chile; Multiple Projects to be Evaluated

MGX Minerals Announces Advancement in Nanofiltration Lithium Technology; Commences Initial Design of 2400 Cubic Meter Per Day Plant

Singlepoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.0704, up 0.57%, on 1,694,050 volume with 204 trades. The stock’s average daily volume over the past 60 days is 12,434,441, and its 52-week low/high is $0.0132/$0.415.

NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions for business, today announces the audio version of a brand awareness article titled "SinglePoint Signs LOI with ORHub to Launch Healthcare Blockchain Initiative,” recently issued by SinglePoint Inc. (OTCQB:SING). To hear the NetworkNewsAudio version, visit: http://nnw.fm/Zkni1. To read the original article, visit: http://nnw.fm/R0dd4.

Singlepoint, Inc. (SING) has grown from a full-service mobile technology provider to a publicly-traded holding company. Through diversification into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued subsidiaries, thereby providing a rich, diversified holding base.

SinglePoint's approach is to first research and identify acquisition opportunities in which it can take an active and influential role among existing leadership to provide enhanced strategy and direction. Target companies are undervalued, cash-flow positive, with high potential and verified assets. SinglePoint acquires and takes controlling interest of successful candidate companies.

SinglePoint recently signed a Letter of Intent to acquire an interest in Jacksam Corp., dba Convectium, a profitable California-based provider of equipment, branding, and packaging solutions for the cannabis industry. Convectium has developed the world's first cartridge and vape pen oil filling machine for wholesale distribution to dispensaries. The 710Shark and 710Seal systems can fill and package over 100 cartridges or disposable vape pens in 30 seconds and are sold to dispensaries through its EquipCanna.com brand. The company also operates a consumer brand that includes BlackoutX and HazeSticks and reaches customers in over 52 countries.

Additionally, SinglePoint has raised more than $300,000 and has signed a Letter of Intent to secure an additional $1 million in funding. The move provides management with ample capital to execute its business plan, while avoiding debt repayments that can eat into cash flow and reduce flexibility over time. It's also a rare development for a development-stage company in the cannabis industry.

Guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital, SinglePoint continues to explore high-potential acquisition opportunities to grow and diversify its current holding base. The company also plans to uplist to the OTCQB and become a fully reporting company during the current fiscal year.

The company has engaged Milost Advisors to pursue acquisitions and financing facilities toward funding acquisitions, as well as to provide working capital. Milost Advisors will assist SinglePoint in the acquisition of undervalued companies with annual revenues of at least $50 million, and has already identified potential acquisition targets for the company to consider. Disclaimer

Singlepoint, Inc. Company Blog

Singlepoint, Inc. News:

NetworkNewsAudio Covers SinglePoint’s Intent to Launch Healthcare Blockchain Initiative with ORHub

NetworkNewsBreaks – SinglePoint, Inc. (SING) Inks LOI with ORHub, Inc. (ORHB) to Launch Healthcare Blockchain Platform

NetworkNewsBreaks – ORHub, Inc. (ORHB) Signs LOI with Singlepoint, Inc. (SING); Launches Healthcare Blockchain Initiative

EVIO, Inc. (EVIO)

The QualityStocks Daily Newsletter would like to spotlight EVIO, Inc. (EVIO). Today, EVIO, Inc. closed trading at $1.342, off by 2.75%, on 45,648 volume with 54 trades. The stock’s average daily volume over the past 60 days is 122,948, and its 52-week low/high is $0.47/$2.70.

EVIO, Inc., (OTCQB: EVIO) a life science company and leading provider of quality control testing and advisory services to the regulated cannabis industry, recently announced that it has opened its first accredited cannabis testing facility in Florida.

EVIO, Inc. (EVIO), via the EVIO Labs division, is the nation's leading provider of accredited analytical testing, scientific research and advisory services to the regulated cannabis industry. EVIO Labs provides state-mandated ancillary services that are required to ensure the safety and quality of the nation's cannabis supply. EVIO Labs has performed over 50,000 tests during the past two years and grown from one laboratory in Oregon to nine labs spanning California, Oregon, Colorado, Massachusetts and Florida.

EVIO Labs is driving the cannabis testing industry by providing clients nationwide with consistent high-quality cannabis analytical services backed by quality control assurances. The company also provides advisory services that help cannabis producers and retailers enhance production processes, achieve regulatory compliance and meet quality goals.

EVIO Labs is on track to open 18 laboratories by the end of 2018 at locations around the United States. The Oregon-based company provides analytical services that include testing cannabis and industrial hemp flower, extracts and infused products. The labs specialize in performing the following tests:

  • Cannabinoid analysis, which properly characterizes the many primary cannabinoids found in cannabis including THC, CBD, and several other cannabinoids.
  • Terpene analysis, which identifies the aromatic compounds of the plant (terpene), which can help identify the therapeutic potential of a cannabis flower or extract.
  • Moisture content and water activity, which measure the moisture levels of dried cannabis and are indicators of microbiological growth potential.
  • Pesticide residue analysis of over 100 different pesticides, herbicides, fungicides, growth regulators and other agrochemicals that may be present on cannabis.
  • Detection of harmful residual solvents left behind in the cannabis extract production process.
  • Microbial testing screen for bacterial and fungal contamination in cannabis and cannabis-infused products.
  • Detection of heavy metals including lead, cadmium, mercury, and arsenic.

EVIO Labs is rapidly becoming the nation's leading cannabis biotechnology company. Led by a management team with extensive experience in designing and rolling out successful business ventures, product research and development, regulatory and compliance protocols, medical cannabis cultivation, production and analytical chemistry techniques, EVIO Labs is prepared to take advantage of today's fastest growing industry. Disclaimer

EVIO, Inc. Company Blog

EVIO, Inc. News:

EVIO to Capitalize on Florida's $3 Billion Cannabis Market

EVIO, Inc. adds Top Executives from Pfizer and Quest Diagnostics to Upper Management

EVIO Inc. Reports Q1 2018 Results

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)

The QualityStocks Daily Newsletter would like to spotlight PreveCeutical Medical Inc. (PRVCF). Today, PreveCeutical Medical Inc. closed trading at $0.38, even for the day, on 33,591 volume with 34 trades. The stock’s average daily volume over the past 60 days is 12,810, and its 52-week low/high is $0.01/$0.80.

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring PreveCeutical Medical Inc. (OTCQB:PRVCF) (CSE:PREV) (FSE:18H), a client of NNW and health sciences company that develops innovative preventive therapies utilizing organic and nature identical products. To view the full publication, titled “A New Breakthrough in Cannabinoid Drug Delivery,” visit: http://nnw.fm/9l2Zl.

PreveCeutical Medical Inc. (PRVCF), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to researching and developing innovative options for preventive and curative therapies utilizing organic and Nature Identical™ products. The company is strategically staking out select positions in the medically acute areas of diabetes and obesity, pain management, neurological disorders and cancer.

PreveCeutical Medical Inc. had its beginnings in 2009 when Stephen Van Deventer, a seasoned businessman and venture capitalist, and Kimberly Van Deventer, a successful entrepreneur, met and formed a business partnership. The duo created Cornerstone Global Partners, a venture capital and business development company, and became involved in numerous ventures including building companies such as Aurora Cannabis Inc. Taking their interest in the health and wellness market further, the pair began researching how nature and science can work together to benefit health-conscious consumers. Coining and trademarking the word "PreveCeutical" – a combination of the words "preventive" and "pharmaceutical" – was a precursor to the company's formation and incorporation in October 2015.

The company's first product was developed in the Dominican Republic and is now marketed and distributed worldwide by PreveCeutical. It is a Caribbean Blue Scorpion venom product sold under the trade name CELLB9®. This product is an oral dilute solution infused with select peptides sourced exclusively from the blue scorpion (Rhopalurus princeps) found only in Caribbean nations. The active potentiated ingredients in CELLB9, which have been used in over 40 countries for over a decade, appear to support health at a deep, cellular level. PreveCeutical's research team is using proprietary chemistry to generate Nature Identical™ peptides derived from natural compounds found in Caribbean Blue Scorpion venom with the goal of eventually treating, regulating and preventing cancer progression. Peptides are also being used to target an array of disease indications including metabolic disorders, pain management, cancers, cardiovascular and infectious diseases.

PreveCeutical is developing the first nose-to-brain delivery system of cannabinoids (CBDs) with a novel process that prepares insoluble drug-containing nano-micelles and successfully incorporating them into a proprietary sol-gels application, essentially creating a targeted drug delivery vehicle. Intended for use via a nasal spray, this unique formulation rapidly gels upon contact with mucosal tissue, which paves the way for direct nose-to-brain delivery. This novel application eliminates first pass metabolism (stomach, intestines, liver), potentially improving bioavailability and delivering extended time release formulations that may alleviate side effects of higher dosage therapeutics. This CBD-based patented formula is projected to be deployed in selected markets with licensed medical marijuana companies within 18 months.

PreveCeutical is working with four leading Australian research centers to develop a curative therapy for diabetes and obesity. This four-year program involves engineering a novel approach that selectively targets the gene that encodes for the protein PTP-1B, which is implicated and over-expressed in both type-2 diabetes and obesity. PreveCeutical's gene-silencing technology would effectively "turn off" the genetic signal which leads to the over-production of this key protein molecule, bringing it back down to safe, normalized levels, and prevent the body from storing excessive fat. Diabetes kills one person every six seconds, with more than $800 billion spent globally on the disease.

Another exciting joint venture, established with Sports 1 Marketing, will focus on the therapeutic potential in the peptides and proteins connected to the Caribbean Blue Scorpion venom to potentially treat mild brain injury concussions. Developing a therapeutic product geared towards athletes who suffer from concussions could help alleviate suffering experienced by those who are affected by head trauma.

PreveCeutical Medical's science and research team is led by Dr. Harendra (Harry) Parekh, Ph.D., who is based at the University of Queensland's (UQ) Pharmacy Australia Centre of Excellence (PACE), and Dr. Makarand Jawadekar, Ph.D., whose 28 years of R&D experience with Pfizer Inc., is applicable in his role as chief science officer. Research collaborators include Dr. Rakesh Veedu, an emerging expert internationally in the field of molecular medicine, and Professor Grant Ramm, who is currently head of a leading medical research institute located in Brisbane, Australia.

PreveCeutical Medical is partnering with leading industry experts and companies in its quest to be a leader in the preventive health sciences sector. Its Research and Development partnership with UniQuest, the main commercialization company for the University of Queensland, provides PreveCeutical with the rights to all intellectual property arising from projects created under the agreement. PreveCeutical Medical Inc.'s management team brings an extensive portfolio of research experience, product development, deep corporate strategy and capital markets leadership to the company's core. Disclaimer

PreveCeutical Medical Inc. Company Blog

PreveCeutical Medical Inc. News:

NetworkNewsWire Announces Publication on Unique New Paradigms in Cannabinoid Drug Delivery

A New Breakthrough in Cannabinoid Drug Delivery

NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Aims to Halt Cancerous Tumor Progression Utilizing Scorpion Venom Product

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

Wolf of Penny Stocks
(IZNN) +230.00%

2.

Trading Concepts
(CHK) +21.67%

3.

MarketBeat
(HSC) +17.01%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251